Skip to Navigation | Skip to Content
Post

Pfizer has begun a study comparing its original COVID-19 vaccine with doses specially tweaked to match the hugely contagious omicron variant
Modern Healthcare

Pfizer has begun a study comparing its original COVID-19 vaccine with doses specially tweaked to match the hugely contagious omicron variant. Pfizer and its partner BioNTech announced the study on Tuesday.